BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 8794495)

  • 1. The deficit syndrome in the DSM-IV Field Trial: I. Alcohol and other drug abuse.
    Kirkpatrick B; Amador XF; Flaum M; Yale SA; Gorman JM; Carpenter WT; Tohen M; McGlashan T
    Schizophr Res; 1996 May; 20(1-2):69-77. PubMed ID: 8794495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Substance abuse in psychotic disorders: associations with affective syndromes. DSM-IV Field Trial Work Group.
    Strakowski SM; Tohen M; Flaum M; Amador X
    Schizophr Res; 1994 Dec; 14(1):73-81. PubMed ID: 7893624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Benzodiazepine use and abuse among patients with severe mental illness and co-occurring substance use disorders.
    Brunette MF; Noordsy DL; Xie H; Drake RE
    Psychiatr Serv; 2003 Oct; 54(10):1395-401. PubMed ID: 14557527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Construct validity of the abuse-dependence distinction as measured by DSM-IV criteria for different psychoactive substances.
    Feingold A; Rounsaville B
    Drug Alcohol Depend; 1995 Aug; 39(2):99-109. PubMed ID: 8529538
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlates of patterns of substance abuse among patients with schizophrenia.
    Cuffel BJ; Heithoff KA; Lawson W
    Hosp Community Psychiatry; 1993 Mar; 44(3):247-51. PubMed ID: 8444435
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anhedonia and social adaptation predict substance abuse evolution in dual diagnosis schizophrenia.
    Potvin S; Stip E; Lipp O; Roy MA; Demers MF; Bouchard RH; Gendron A
    Am J Drug Alcohol Abuse; 2008; 34(1):75-82. PubMed ID: 18161645
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Concurrent validity of clinicians' ratings of substance abuse among psychiatric outpatients.
    Carey KB; Cocco KM; Simons JS
    Psychiatr Serv; 1996 Aug; 47(8):842-7. PubMed ID: 8837156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DSM-III, DSM-IV and ICD-10 as severity scales for drug dependence.
    Langenbucher JW; Morgenstern J; Miller KJ
    Drug Alcohol Depend; 1995 Aug; 39(2):139-50. PubMed ID: 8529533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Comparative study of substance dependence comorbidity in bipolar, schizophrenic and schizoaffective disorders].
    Verdoux H; Mury M; Besançon G; Bourgeois M
    Encephale; 1996; 22(2):95-101. PubMed ID: 8706627
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DSM-IV, DSM-III-R, and ICD-10 alcohol and drug abuse/harmful use and dependence, United States, 1992: a nosological comparison.
    Grant BF
    Alcohol Clin Exp Res; 1996 Nov; 20(8):1481-8. PubMed ID: 8947328
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is substance abuse in schizophrenia related to impulsivity, sensation seeking, or anhedonia?
    Dervaux A; Baylé FJ; Laqueille X; Bourdel MC; Le Borgne MH; Olié JP; Krebs MO
    Am J Psychiatry; 2001 Mar; 158(3):492-4. PubMed ID: 11229997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cannabis and schizophrenia: demographic and clinical correlates].
    Dervaux A; Laqueille X; Bourdel MC; Leborgne MH; Olié JP; Lôo H; Krebs MO
    Encephale; 2003; 29(1):11-7. PubMed ID: 12640322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Schizophrenia and substance dependence].
    Uchtenhagen A
    Schweiz Arch Neurol Psychiatr (1985); 1995; 146(5):215-23. PubMed ID: 8658102
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Depressive symptoms and the deficit syndrome of schizophrenia.
    Kirkpatrick B; Buchanan RW; Breier A; Carpenter WT
    J Nerv Ment Dis; 1994 Aug; 182(8):452-5. PubMed ID: 8040655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Construct validity of the dependence syndrome as measured by DSM-IV for different psychoactive substances.
    Feingold A; Rounsaville B
    Addiction; 1995 Dec; 90(12):1661-9. PubMed ID: 8555957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationships between symptoms of schizophrenia and substance abuse.
    Brunette MF; Mueser KT; Xie H; Drake RE
    J Nerv Ment Dis; 1997 Jan; 185(1):13-20. PubMed ID: 9040528
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Psychopathologic differences between cannabis-induced psychoses and recent-onset primary psychoses with abuse of cannabis.
    Rubio G; Marín-Lozano J; Ferre F; Martínez-Gras I; Rodriguez-Jimenez R; Sanz J; Jimenez-Arriero MA; Carrasco JL; Lora D; Jurado R; López-Trabada JR; Palomo T
    Compr Psychiatry; 2012 Nov; 53(8):1063-70. PubMed ID: 22682680
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The DSM-IV field trial for substance use disorders: major results.
    Cottler LB; Schuckit MA; Helzer JE; Crowley T; Woody G; Nathan P; Hughes J
    Drug Alcohol Depend; 1995 Apr; 38(1):59-69; discussion 71-83. PubMed ID: 7648998
    [No Abstract]   [Full Text] [Related]  

  • 19. Novelty-seeking among schizophrenia patients with comorbid alcohol abuse.
    Kim JH; Kim D; Park SH; Lee HB; Chung EK
    J Nerv Ment Dis; 2007 Jul; 195(7):622-4. PubMed ID: 17632255
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expectations and motives for substance use in schizophrenia.
    Mueser KT; Nishith P; Tracy JI; DeGirolamo J; Molinaro M
    Schizophr Bull; 1995; 21(3):367-78. PubMed ID: 7481568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.